Avelas Biosciences
PrivateLast Round
Accelerator
Jun 17, 2019
Total Funding Raised
$35.05M
Company Overview
Avelas Biosciences is a biotechnology company that develops fluorescent imaging technologies for real-time cancer detection and visualization during surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avelas Biosciences Comparables
Compare Avelas Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blaze Bioscience, Inc. | 92% | |
| SurgiMab | 83% | |
| Vergent Bioscience | 81% |
Avelas Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 17, 2019 | ||||
| Series C | Aug 18, 2016 | ||||
| Series B | Sep 10, 2014 | ||||
| Series A | Dec 6, 2012 |
Avelas Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| WuXi Healthcare Ventures | Series C |
| Avalon Ventures | Series C, Series A, Series B |
| Torrey Pines Investment LLC | Series B |
| Alexandria Venture Investments | Series C |
| Pharmstandard International S.A. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 6, 2012
$7.65M round led by Avalon Ventures
Avelas Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avelas Biosciences's valuation, stock price, and market status.
Is Avelas Biosciences a public or private company?
Avelas Biosciences is a private company.
What is the current stock price of Avelas Biosciences?
Avelas Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Avelas Biosciences worth (valuation)?
Valuation information for Avelas Biosciences is not publicly available.
Can I buy Avelas Biosciences stock?
Avelas Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Avelas Biosciences's last funding round?
Avelas Biosciences's most recent funding round was Accelerator on June 17, 2019.
Who are the main investors in Avelas Biosciences?
Key investors in Avelas Biosciences include MedTech Innovator, Avalon Ventures, Pharmstandard International S.A..
Will Avelas Biosciences IPO soon?
No public IPO plans have been announced for Avelas Biosciences.
How can I track Avelas Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avelas Biosciences's secondary market activity and sign up for updates.